Navelbine and anorexia Patient Reports February 11, 2012

Navelbine Side Effects Report #4694651-7
Navelbine side effect was reported by a Physician from on May 29, 2003. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain , choking , constipation , cough, cyanosis, disease progression, dyspnoea exacerbated. Navelbine dosage: 25MGM2 PER DAY. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 05/12/2003.

Navelbine Side Effects Report #5279693-5
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Male patient, 58 years of age, was diagnosed with neoplasm malignant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, dehydration, nausea . Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5282906-7
Navelbine side effect was reported by a Consumer or non-health professional from NETHERLANDS on Mar 05, 2007. Male patient, 58 years of age, was diagnosed with neoplasm malignant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, dehydration, nausea . Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4598253-2
Navelbine side effect was reported by a Physician from on Feb 25, 2005. Male patient, 76 years of age, was diagnosed with lymphoma  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, cough, delirium, febrile neutropenia, lobar pneumonia, malaise, oesophageal candidiasis, pharyngolaryngeal pain. Navelbine dosage: 37.5MG CYCLIC. During the same period patient was treated with GEMZAR, IFOSFAMIDE, PEGFILGRASTIM. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #4907170-7
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Nov 17, 2005. Male patient, 77 years of age, was diagnosed with lung neoplasm malignant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea. Navelbine dosage: unknown. During the same period patient was treated with VINORELBINE TARTRATE, OMEPRAZOLE, CIPROXAN, SULTAMUGIN, PAZUCROSS, SPIRIVA, SEREVENT, NAUZELIN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4706452-1
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2005. Female patient, 87 years of age, was diagnosed with lung cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, acute respiratory failure, anorexia, asthenia, blood glucose increased, caecitis, chills, constipation . Navelbine dosage: 32.5MG PER DAY. During the same period patient was treated with NORVASC, FOSAMAX, ENALAPRIL MALEATE, METOCLOPRAMIDE, MYCELEX, GEMZAR. Patient was hospitalized. Patient died on 08/17/2004.

Navelbine Side Effects Report #4705379-9
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2005. Female patient was diagnosed with lung cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal distension, anorexia, asthenia, blood glucose increased, chills, constipation , diarrhoea, dysphagia, fatigue. Navelbine dosage: 32.5MG PER DAY. During the same period patient was treated with NORVASC, FOSAMAX, ENALAPRIL MALEATE, METOCLOPRAMIDE, MYCELEX. Patient was hospitalized. Patient died on 08/17/2004.

Navelbine Side Effects Report #4592924-X
Navelbine side effect was reported by a Health Professional from on Feb 25, 2005. Female patient, 54 years of age, was diagnosed with lung adenocarcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, clostridium colitis, diarrhoea, hyponatraemia, klebsiella infection, leukopenia, malaise, pyrexia, vomiting. Navelbine dosage: 34MG PER DAY. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5933646-X
Navelbine side effect was reported by a Consumer or non-health professional from FRANCE on July 03, 2008. Female patient, 62 years of age, weighting 160.9 lb, was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, hypokalaemia, refusal of treatment by patient, vomiting. Navelbine dosage: 20 MG/M2 IV. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5281149-0
Navelbine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 07, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, malignant neoplasm progression, metastasis, pulmonary oedema, snoring . Navelbine dosage: 0 MG/M2 DAILY IV. Patient died on 12/27/2006.

Navelbine Side Effects Report #4704975-2
Navelbine side effect was reported by a Consumer or non-health professional from on June 29, 2005. Male patient, weighting 165.3 lb, was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , chest x-ray abnormal, depression , fatigue, febrile neutropenia, lung neoplasm malignant. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.